Current clinical practice trends in giant cell arteritis diagnosis and management: a national survey of Australian rheumatologists and rheumatology trainees
Internal Medicine Journal · 2026
DOI: 10.1111/imj.70319 ↗Kurz gefasst
Fachartikel in der Zeitschrift Internal Medicine Journal, 2026. Verfasst von Jem Ninan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Medicine, The University of Adelaide, Adelaide, South Australia, Australia. Hauptthemen laut MEDLINE: Giant Cell Arteritis, Rheumatology, Rheumatologists, Practice Patterns, Physicians'. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Hospital Research Foundation, The Northern Community Health and Research Foundation (NCHRF), Australian Government Research Training Program Scholarship.
Abstract (Originalsprache)
Introduction
Giant cell arteritis (GCA) is the most common vasculitis of the elderly. Delayed diagnosis or inadequate treatment can lead to severe and irreversible consequences. There are limited data on diagnosis and management practices of rheumatologists and rheumatology trainees in Australia. This study aimed to determine practices and views of Australian rheumatologists/rheumatology trainees in the diagnosis and management of GCA.
Methods
An online survey was completed by Australian rheumatologists/trainees. The survey gathered data on the respondent demographics and a range of topics related to the diagnosis and management of GCA, including the use of temporal artery biopsy (TAB) and imaging, confidence in ultrasound, use of steroid‐sparing medication, and approaches to aortic aneurysm screening and referral back to primary care.
Results
There were 58 respondents (52 rheumatologists, six trainees). On average, respondents used TAB alone (56% of respondents), imaging alone (19%), both (15%) or neither (10%). The majority of respondents (79%) rarely or never made a diagnosis of GCA without TAB. Only 40% expressed confidence in GCA diagnosis by temporal artery ultrasound from their preferred radiology provider. Management approaches following the end of government‐funded tocilizumab varied. Only 12% of respondents reported that >50% of their GCA patients were able to cease prednisolone by 12 months.
Conclusions
Australian rheumatologists and trainees have low confidence in ultrasound and rarely make a diagnosis of GCA without a TAB. Variable practice would support the need to develop Australian clinical care standards for GCA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Discipline of Medicine, The University of Adelaide, Adelaide, South Australia, Australia.
- Rheumatology Unit, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia.
- Rheumatology Unit, Modbury Hospital, Adelaide, South Australia, Australia.
- Department of Rheumatology, Austin Health, Melbourne, Victoria, Australia.
- Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
- School of Public Health, The University of Adelaide, Adelaide, South Australia, Australia.
ORCID-Profile: Jem Ninan, Jessica Leung, David Liew
Förderung
- Hospital Research Foundation
- The Northern Community Health and Research Foundation (NCHRF)
- Australian Government Research Training Program Scholarship
Zitieren
APA
Ninan, J., Leung, J., Liew, D., Lester, S., Stanhope, J., McNeil, J., & Hill, C. L. (2026). Current clinical practice trends in giant cell arteritis diagnosis and management: a national survey of Australian rheumatologists and rheumatology trainees. Internal Medicine Journal. https://doi.org/10.1111/imj.70319
Vancouver
Ninan J, Leung J, Liew D, Lester S, Stanhope J, McNeil J, et al. Current clinical practice trends in giant cell arteritis diagnosis and management: a national survey of Australian rheumatologists and rheumatology trainees. Internal Medicine Journal. 2026. doi:10.1111/imj.70319
BibTeX
@article{Ninan2026,
author = {Ninan, Jem and Leung, Jessica and Liew, David and Lester, Susan and Stanhope, Jessica and McNeil, Julian and Hill, Catherine L},
title = {Current clinical practice trends in giant cell arteritis diagnosis and management: a national survey of Australian rheumatologists and rheumatology trainees},
journal = {Internal Medicine Journal},
year = {2026},
doi = {10.1111/imj.70319}
}
EUVIMED